Huahong花红品牌怎么样 申请店铺

我要投票 Huahong花红在女性洗液行业中的票数:1130 更新时间:2026-10-14
Huahong花红是哪个国家的品牌?「Huahong花红」是 广西壮族自治区花红药业股份有限公司 旗下著名品牌。该品牌发源于广西,由创始人韦飞燕在1982期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力Huahong花红品牌出海!将品牌入驻外推网,定制Huahong花红品牌推广信息,可以显著提高Huahong花红产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

Huahong花红怎么样

广西花红药业股份有限公司集药材基地、科研、生产、销售为一体,是国家重点中成药企业,始建于20世纪70年代初。2002年完成国有改制,与上海复星医药(集团)股份有限公司进行合资合作,充分运用复星医药的资金、技术、管理等综合资源,在现代中药、药材种植、医药流通、资本运营等领域实现共赢;2005年花红品牌向健康产业延伸,建立子公司花红俱乐部。

花红药业拥有“花红”驰名保护和40多项国家专利,改制后投入巨资改造现代中药的软硬件设施,通过了GMP、CGMP,达到国际注册标准,是广西区技术中心、国家级高新技术企业。

花红药业GMP生产基地占地200亩、年生产能力达10亿元以上,生产能力规模居广西中成药行业首位。公司拥有以妇科产品为主的中成药50多个品种,包括国家中药保护品种花红片、花红颗粒、葛根芩连丸、消肿止痛酊,以及花红随身洁、养血当归糖浆等。其中独家品种花红片、花红颗粒、花红胶囊、消肿止痛酊、葛根芩连丸、解毒生肌膏入选国家《药品目录(2009年版)》。治疗流感、腹泻的独家产品葛根芩连丸是全国中医院急诊必备用药,由于具有抗病毒、起效快特点,多次在国家发生大的疫情时,被国家卫生部推荐为诊疗用药。主导产品花红片、消肿止痛酊是全国治疗妇科炎症用药和外用镇痛酊剂类用药的知名品牌。

花红药业奉行“关心健康,爱护家庭”的宗旨,秉承“坦诚、开放、严谨、感恩”的企业理念,致力于女性健康事业,为改善和提高女性健康水平,提供专业化的优质药品和服务,发展以品牌为核心的妇科产品群,努力成为中国乃至全球女性用药的一流企业和女性健康专家。

Guangxi Huahong Pharmaceutical Co., Ltd. is a national key Chinese patent medicine enterprise, which integrates the base of medicinal materials, scientific research, production and sales. It was founded in the early 1970s. In 2002, the state-owned restructuring was completed, and a joint venture cooperation was carried out with Shanghai Fosun Pharmaceutical (Group) Co., Ltd. to make full use of Fosun Pharmaceutical's capital, technology, management and other comprehensive resources to achieve a win-win situation in the fields of modern Chinese medicine, herbal medicine planting, pharmaceutical circulation, capital operation, etc.; in 2005, Huahong brand extended to the health industry and established a subsidiary Huahong club. Huahong Pharmaceutical Co., Ltd. is well-known for its "Huahong" protection and more than 40 national patents. After the reform, it invested heavily in the reconstruction of the software and hardware facilities of modern Chinese medicine, passed GMP and cGMP, and reached the international registration standard. It is a technology center of Guangxi district and a national high-tech enterprise. Huahong pharmaceutical GMP production base covers an area of 200 mu, with an annual production capacity of more than 1 billion yuan, ranking first in Guangxi's proprietary Chinese medicine industry. The company has more than 50 kinds of traditional Chinese medicine mainly for gynecology products, including Huahong tablet, Huahong granule, Gegen Qinlian pill, Xiaozhong Zhitong tincture, Huahong portable cleaning, blood nourishing Angelica syrup, etc. Among them, the exclusive varieties of Huahong tablet, Huahong granule, Huahong capsule, Xiaozhongzhitong tincture, Gegenqinlian pill and Jiedu Shengji ointment were selected into the National Drug Catalogue (2009 Edition). Gegen Qinlian pill, an exclusive product for the treatment of influenza and diarrhea, is an essential medicine for emergency treatment in Chinese medicine hospitals. Because of its antiviral and quick effect, it has been recommended by the Ministry of health as a medicine for diagnosis and treatment when there are many large epidemics in the country. Huahong tablet and Xiaozhongzhitong tincture, the leading products, are well-known brands for the treatment of gynecological inflammation and external analgesic tincture. Huahong pharmaceutical adheres to the tenet of "caring for health, caring for family", adheres to the enterprise concept of "honesty, openness, preciseness and gratitude", devotes itself to the cause of women's health, provides professional high-quality drugs and services for improving and improving women's health level, develops the gynaecological product group with brand as the core, and strives to become the first-class enterprise and women's medicine in China and even in the world Health experts.

本文链接: https://brand.waitui.com/f7cc93a62.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

报道:DeepSeek重启融资,投前估值5000亿元

多名交易人士透露,大模型公司DeepSeek重启了第二轮融资,本轮计划募资500亿元,投前估值约5000亿元,并计划将在8月下旬完成签约。DeepSeek在今年4月开启了首轮融资,并在6月完成交割,该轮融资金额500亿元,估值超过3500亿元,成为中国AI大模型史上首轮融资规模最大的公司。多位投资人提到,DeepSeek第二轮融资至少在7月中旬就已开启,但在7月底突然暂停,当时一些谈判候补名单上的投资人被告知签署融资协议的计划暂缓。(财经杂志)

2026-08-05

中国7月RatingDog服务业PMI 50.4,前值54.1

36氪获悉,中国7月RatingDog服务业PMI 50.4,前值54.1。

2026-08-05

A股三大指数全线翻红

36氪获悉,A股三大指数全线翻红,存储芯片、先进封装、MLCC概念等方向涨幅居前。全市场上涨个股超3500只。

2026-08-05

京东:开源实时流式视频编辑模型JoyAI-Video-Edit

36氪获悉,据京东黑板报消息,8月5日,京东宣布开源自研的实时流式视频编辑模型JoyAI-Video-Edit。据介绍,用户可以一边观看视频,一边修改人物与场景,让视频创作从“先有素材再修改”变为可实时互动编辑。

2026-08-05

中际旭创回应“美国光模块禁令”影响:因并未出台 暂时不予评述

光模块概念股中际旭创、新易盛、天孚通信盘中分别跌7.93%、4.96%、3.4%。有市场消息称,美国联邦通信委员会(FCC)正在起草一项禁令,旨在禁止美国进口中国数据中心组件新机型,包括光模块。今日记者以投资人身份拨打中际旭创证券事务代表电话,相关负责人称,公司已注意到相关市场信息,经核实,FCC尚未出台相关领域限制性文件。就禁令出台后的影响,相关负责人称,因并未出台,暂时不予评述。(第一财经)

2026-08-05

本页详细列出关于Huahong花红的品牌信息,含品牌所属公司介绍,Huahong花红所处行业的品牌地位及优势。
咨询